BPC-157 & KPV Peptides: A New Hope for Managing MCAS
BPC-157 and KPV peptides have drawn increasing interest in the treatment of mast cell activation syndrome (MCAS) due to their anti-inflammatory properties, ability to stabilize cellular membranes,.